Clonal and genomic determinants of e1a2 BCR::ABL1 chronic myeloid leukemia: A Fi‐LMC study
Benjamin Podvin, Olivier Nibourel, Sandrine Hayette, Valérie Coiteux et autres
0 citationsHemaSphere
Valérie Coiteux
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
126Publications signalées
1740Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia ResearchAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationMultiple Myeloma Research and Treatments
Publications récentes
ORAL ABSTRACT: CML-652: ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML
Fadi G Haddad, Dennis Dong Hwan Kim, Fabian Lang, Michael Mauro et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
POSTER: CML-652: ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML
Fadi G Haddad, Dennis Dong Hwan Kim, Fabian Lang, Michael Mauro et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
CML-652: ENABLE: A Phase 1 Study of ELVN-001, a Novel, Selective ATP-Competitive Inhibitor of BCR::ABL1, in Patients With Previously Treated CP-CML
Fadi G Haddad, Dennis Dong Hwan Kim, Fabian Lang, Michael Mauro et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
Molecular landscape and clonal evolution in minor versus major BCR::ABL1 chronic myeloid leukemia under tyrosine kinase inhibition : A Study from the french group fi-LMC
Benjamin Podvin, Olivier Nibourel, Sandrine Hayette, Valérie Coiteux et autres
1 citationBlood
Preliminary safety and efficacy of ELVN-001, a selective active site inhibitor of BCR::ABL1, in patients with CML driven by atypical fusion transcripts
Andreas Hochhaus, Susanne Saußele, Valérie Coiteux, Dong-Wook Kim et autres
2 citationsBlood
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia. a randomized national fi-LMC comparative trial of two therapeutic strategies.
Émilie Cayssials, Frédéric Bauduer, Viviane Dubruille, Valérie Coiteux et autres
0 citationsBlood
Development and Validation of the FIP Score for the Screening of FIP1L1::PDGFRA-Associated Hypereosinophilic Syndrome
Romain Stammler, Alexandre Vallée, Julien Rohmer, Nathalie Grardel et autres
3 citationsThe Journal of Allergy and Clinical Immunology In Practice
POSTER: CML-920 Treatment-Free Remission in Chronic Myeloid Leukemia With Rare ABL1 Gene Fusions
Delphine Réa, Aude Charbonnier, Gabriel Étienne, Lydia Roy et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
CML-920: Treatment-Free Remission in Chronic Myeloid Leukemia With Rare ABL1 Gene Fusions
Aude Charbonnier, Gabriel Étienne, Lydia Roy, Laurence Legros et autres
0 citationsClinical Lymphoma Myeloma & Leukemia
Acute myeloid leukemia after CAR T-cell therapy: role of pre-existing clonal hematopoiesis and inflammation in leukemogenesis
Paul Chauvet, Cynthia Saade, Julie Demaret, David Beauvais et autres
1 citationBone Marrow Transplantation
Anticipation des problèmes pharmacothérapeutiques en amont de l’allogreffe (SFGM-TC)
Nicolas Simon, Agnès Bonnin, Alexia Jouvance, Stavroula Masouridi‐Levrat et autres
0 citationsBulletin du Cancer
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.